Cited by 355Liver Disease and TransplantationSepsis Diagnosis and TreatmentAlcohol Consumption and Health Effects

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophaegeal varices, and hyperdynamic circulation.

Lin, Ren-Shin, Lee, Fa-Yauh, Lee, Shou-Dong, Tsai, Yang-Te, Lin, Han Chieh, Rei-Hwa, Lu, Wan-Ching, Hsu, Cheng-Chun, Huang, Sun-Sang, Wang, Kwang-Juei, Lo·1995·Journal of Hepatology

DOI 10.1016/0168-8278(95)80424-2

Open this paper in CoChat — free account

Abstract

Plasma endotoxin levels were investigated using a quantitative Limulus assay in patients with chronic liver diseases and correlated with the severity of liver diseases, the presence of esophageal varices, and hemodynamic parameters. The plasma endotoxin levels were significantly higher in chronic hepatitis patients with acute exacerbation (10.1 +/- 1.3 pg/ml, n = 13, p < 0.05) and patients with cirrhosis (7.0 +/- 0.7 pg/ml, n = 126, p < 0.05) than in healthy subjects (2.9 +/- 0.2 pg/ml, n = 45). Chronic hepatitis patients (n = 30) had plasma endotoxin levels which were similar to those in healthy subjects (4.6 +/- 0.5 vs. 2.9 +/- 0.2 pg/ml, p > 0.05) but lower than those in chronic hepatitis patients with acute exacerbation (4.6 +/- 0.5 vs. 10.1 +/- 1.3 pg/ml, p < 0.05). Endotoxemia (plasma endotoxin level > 5.7 pg/ml) was found in 27%, 85% and 41% of patients with chronic hepatitis, chronic hepatitis with acute exacerbation, and cirrhosis, respectively. In patients with cirrhosis, the plasma endotoxin levels progressively increased in relation to the severity of liver dysfunction (Pugh's class A/B/C = 4.9 +/- 0.5/7.9 +/- 1.4/10.2 +/- 2.0 pg/ml, p < 0.05). In contrast, plasma endotoxin levels were comparable between patients with cirrhosis with and without esophageal varices (p > 0.05). Chronic hepatitis patients with acute exacerbation (no collaterization) had much higher plasma endotoxin levels than those in patients with cirrhosis and large varices (p < 0.05), whereas compensated patients with cirrhosis and large esophageal varices had plasma endotoxin levels similar to those seen in chronic hepatitis patients (no collaterization) (p > 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Integrity signals

Registry

Crossref · 10.1016/0168-8278(95)80424-2

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941
Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
Schrier, R. W., Arroyo, V., Bernardi, M., Epstein, M., Henriksen, J. H., & Rodés, J. (1988) · Hepatology · doi:10.1002/hep.1840080532 · Cited by 1,616
Biosynthesis of nitric oxide from l-arginine
Moncada, S., Palmer, R. M. J., & Higgs, E. A. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90403-6 · Cited by 1,222
The cardiovascular response of normal humans to the administration of endotoxin.
Suffredini, A., Fromm, R., Parker, M., Brenner, M., Kovacs, J., Wesley, R., & Parrillo, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210503 · Cited by 1,133
Prediction of variceal hemorrhage by esophageal endoscopy
Beppu, K., Inokuchi, K., Koyanagi, N., Nakayama, S., Sakata, H., Kitano, S., & Kobayashi, M. (1981) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(81)73224-3 · Cited by 758
Hyperdynamic circulation in cirrhosis: A role for nitric oxide?
Vallance, P., & Moncada, S. (1991) · The Lancet · doi:10.1016/0140-6736(91)91384-7 · Cited by 615
Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock
Rees, D. D., Cellek, S., Palmer, R. M. J., & Moncada, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80068-3 · Cited by 590
Thermodilution cardiac output determination with a single flow-directed catheter
Forrester, J. S., Ganz, W., Diamond, G. A., McHugh, T., Chonette, D., & Swan, H. J. C. (1972) · American Heart Journal · doi:10.1016/0002-8703(72)90429-2 · Cited by 500
Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia
Guarner, C., Soriano, G., Tomas, A., Bulbena, O., Novella, M. T., Balanzo, J., Vilardell, F., Mourelle, M., & Moncada, S. (1993) · Hepatology · doi:10.1002/hep.1840180520 · Cited by 489
Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay
Fukui, H., Brauner, B., Bode, J. C., & Bode, C. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90933-3 · Cited by 461

Show all 40 references

Sorted by citations

Items 101–200 of 355

Pathogenesis of hepatic encephalopathy: the tumour necrosis factor‐α theory
Odeh, M. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01778.x · Cited by 78
The Gut Microbiome in Intestinal Fibrosis: Environmental Protector or Provocateur?
Rieder, F. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004731 · Cited by 78
Intestinal microbiota in liver disease
Haque, T., & Barritt, A. S. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.02.004 · Cited by 76
Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double‐blind, placebo‐controlled trial
Kimer, N., Pedersen, J. S., Busk, T. M., Gluud, L. L., Hobolth, L., Krag, A. A., Møller, S., Bendtsen, F., & Copenhagen Rifaximin (CoRif) Study Group (2016) · Hepatology · doi:10.1002/hep.28898 · Cited by 78
Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality
Russo, M. W., Sood, A., Jacobson, I. M., & Brown, R. S. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)01697-6 · Cited by 74
Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
Malnick, S. D. H., Alin, P., Somin, M., & Neuman, M. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416226 · Cited by 78
Anatomical localization of commensal bacteria in immune cell homeostasis and disease
Fung, T. C., Artis, D., & Sonnenberg, G. F. (2014) · Immunological Reviews · doi:10.1111/imr.12186 · Cited by 75
Comparison of the Gut Microbe Profiles and Numbers Between Patients with Liver Cirrhosis and Healthy Individuals
Liu, J., Wu, D., Ahmed, A., Li, X., Ma, Y., Tang, L., Mo, D., Ma, Y., & Xin, Y. (2012) · Current Microbiology · doi:10.1007/s00284-012-0105-8 · Cited by 70
Low serum concentration of apolipoprotein A-I is an indicator of poor prognosis in cirrhotic patients with severe sepsis
Tsai, M.-H., Peng, Y.-S., Chen, Y., Lien, J., Tian, Y., Fang, J., Weng, H., Chen, P., Yang, C., & Wu, C. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.024 · Cited by 68
Intrahepatic CD206+ macrophages contribute to inflammation in advanced viral-related liver disease
Tan-Garcia, A., Wai, L.-E., Zheng, D., Ceccarello, E., Jo, J., Banu, N., Khakpoor, A., Chia, A., Tham, C. Y. L., Tan, A. T., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.04.023 · Cited by 68
Review article: the reversibility of cirrhosis
Sohrabpour, A. A., Mohamadnejad, M., & Malekzadeh, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12044 · Cited by 80
Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites
Alam, I., Bass, N. M., Bacchetti, P., Gee, L., & Rockey, D. C. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00743-1 · Cited by 66
Rifaximin has minor effects on bacterial composition, inflammation, and bacterial translocation in cirrhosis: A randomized trial
Kimer, N., Pedersen, J. S., Tavenier, J., Christensen, J. E., Busk, T. M., Hobolth, L., Krag, A. A., Al‐Soud, W. A., Mortensen, M. S., Sørensen, S. J., et al. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13852 · Cited by 69
Liver injury is associated with mortality in sickle cell disease
Feld, J. J., Kato, G. J., Koh, C., Shields, T., Hildesheim, M. E., Kleiner, D. E., Taylor, J. G., Utay, N. S., Douek, D. C., Haynes–Williams, V., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13347 · Cited by 64
Toll-like receptors as therapeutic targets in gastrointestinal diseases
Pimentel‐Nunes, P., Soares, J., Roncon‐Albuquerque, R., Dinis-Ribeiro, M. J., & Leite-Moreira, A. F. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003642027 · Cited by 70
Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation
von Baehr, V., Döcke, W. D., Plauth, M., Liebenthal, C., Küpferling, S., Lochs, H., Baumgarten, R., & Volk, H. (2000) · Gut · doi:10.1136/gut.47.2.281 · Cited by 63
Increased toll‐like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy
Jayakumar, A. R., Tong, X., Curtis, K. M., Ruiz‐Cordero, R., Abreu, M. T., & Norenberg, M. D. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12516 · Cited by 63
Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis
Dong, T. S., Aronsohn, A. I., Reddy, K. G., & Te, H. S. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4313-0 · Cited by 65
A Predictive Model Based on the Gut Microbiota Improves the Diagnostic Effect in Patients With Cholangiocarcinoma
Zhang, T., Zhang, S., Chen, J., Lin, Z., Deng, T., Xie, X., Deng, L., Li, X., Ma, J., Ding, X., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.751795 · Cited by 62
Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis
Czaja, A. J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i42.9257 · Cited by 63
Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication
Bettenworth, D., & Rieder, F. (2017) · Digestive Diseases · doi:10.1159/000449079 · Cited by 62
Liver fibrosis and CD206+ macrophage accumulation are suppressed by anti-GM-CSF therapy
Tan-Garcia, A., Lai, F., Yeong, J. P.-S., Irac, S. E., Ng, P. Y., Msallam, R., Lim, J. C. T., Wai, L., Tham, C. Y. L., Choo, S. P., et al. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.11.006 · Cited by 63
Reference standard for serum bile acids in pregnancy
Egan, N., Bartels, A., Khashan, A. S., Broadhurst, D., Joyce, C. M., O’Mullane, J., & O’Donoghue, K. (2012) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.03245.x · Cited by 61
HCV-Related Proteins Activate Kupffer Cells Isolated from Human Liver Tissues
Hosomura, N., Kono, H., Tsuchiya, M., Ishii, K., Ogiku, M., Matsuda, M., & Fujii, H. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1395-y · Cited by 61
Plasma endotoxin level of healthy donors
Nádházi, Z., Takáts, A., Offenmüller, K., & Bertók, L. (2002) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.49.2002.1.15 · Cited by 60
Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all‐cause admissions in patients on the liver transplant waiting list
Salehi, S., Tranah, T. H., Lim, S., Heaton, N. D., Heneghan, M. A., Aluvihare, V. R., Patel, V., & Shawcross, D. L. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15326 · Cited by 61
B. thetaiotaomicron -derived acetic acid modulate immune microenvironment and tumor growth in hepatocellular carcinoma
Ma, H., Yang, L., Liang, Y., Liu, F., Hu, J., Zhang, R., Li, Y., Yuan, L., & Feng, F. (2024) · Gut Microbes · doi:10.1080/19490976.2023.2297846 · Cited by 62
Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis
Chen, C., Li, L., Wu, Z., Chen, H., & Fu, S. (2006) · Journal of Infection · doi:10.1016/j.jinf.2005.11.013 · Cited by 60
The role of DNA damage and repair in liver cancer
Gillman, R., Floro, K. L., Wankell, M., & Hebbard, L. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188493 · Cited by 57
Mechanisms of Tissue Remodeling in Inflammatory Bowel Disease
Rieder, F., & Fiocchi, C. (2013) · Digestive Diseases · doi:10.1159/000353364 · Cited by 59
Markers of bacterial translocation in end-stage liver disease
Koutsounas, I. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i20.2264 · Cited by 55
Intestinal Permeability Is a Mechanical Rheostat in the Pathogenesis of Liver Cirrhosis
Nishimura, N., Kaji, K., Kitagawa, K., Sawada, Y., Furukawa, M., Ozutsumi, T., Fujinaga, Y., Tsuji, Y., Takaya, H., Kawaratani, H., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136921 · Cited by 58
HGF and Direct Mesenchymal Stem Cells Contact Synergize to Inhibit Hepatic Stellate Cells Activation through TLR4/NF-kB Pathway
Wang, P.-P., Xie, D.-Y., Liang, X.-J., Peng, L., Zhang, G.-L., Ye, Y.-N., Xie, C., & Gao, Z.-L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043408 · Cited by 55
Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota
Garcovich, M. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i46.6693 · Cited by 56
Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulation
Campillo, B., Bories, P. N., Benvenuti, C., & Dupeyron, C. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80242-x · Cited by 55
Lipopolysaccharides induced increases in Fas ligand expression by Kupffer cells via mechanisms dependent on reactive oxygen species
Uchikura, K., Wada, T., Hoshino, S., Nagakawa, Y., Aiko, T., Bulkley, G. B., Klein, A. S., & Sun, Z. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00314.2003 · Cited by 54
Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis
Campion, D., Giovo, I., Ponzo, P., Saracco, G. M., Balzola, F. A., & Alessandria, C. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i6.489 · Cited by 57
Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function
Tsai, Y., Lin, H., Yang, M. C. M., Lee, F.-Y., Hou, M., CHEN, L., & Lee, S. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80034-4 · Cited by 53
Self-citation
Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step
Fukui, H. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00008 · Cited by 55
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Rodrigues, S. G., der Merwe, V., Krag, A. A., & Wiest, R. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2023.101859 · Cited by 51
Toll‐like receptor signaling in liver regeneration, fibrosis and carcinogenesis
Seki, E., Park, E., & Fujimoto, J. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00822.x · Cited by 52
Gut dysbiosis, endotoxemia and clotting activation: A dangerous trio for portal vein thrombosis in cirrhosis
Violi, F., Pignatelli, P., Castellani, V., Carnevale, R., & Cammisotto, V. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.100998 · Cited by 52
Probiotics and Liver Disease
Sheth, A. A., & García–Tsao, G. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318169c44e · Cited by 50
Alcoholic Cirrhosis and Hepatocellular Carcinoma
Stickel, F. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-09614-8_7 · Cited by 48
Störungen des angeborenen Immunsystems bei akuten und chronischen Lebererkrankungen
Leber, B., Mayrhauser, U., Rybczynski, M., & Stadlbauer, V. (2009) · Wiener klinische Wochenschrift · doi:10.1007/s00508-009-1288-2 · Cited by 49
Cross talk between toll‐like receptor‐4 signaling and angiotensin‐II in liver fibrosis development in the rat model of non‐alcoholic steatohepatitis
Shirai, Y., Yoshiji, H., Noguchi, R., Kaji, K., Aihara, Y., Douhara, A., Moriya, K., Namisaki, T., Kawaratani, H., & Fukui, H. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12112 · Cited by 47
Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients
Medrano, L. M., García‐Broncano, P., Berenguer, J., González‐García, J., Jiménez‐Sousa, M. Á., Guardiola, J. M., Casal, M. C., Quereda, C., Sanz, J., Canorea, I., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001787 · Cited by 47
The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors
Zhang, L., Chen, C., Chai, D., Li, C., Guan, Y., Liu, L., Kuang, T., Deng, W., & Wang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956533 · Cited by 47
Portal Vein Thrombosis in Cirrhosis
Raja, K., Jacob, M. O., & Asthana, S. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2013.12.003 · Cited by 46
Differential expression and localization of nitric oxide synthases in cirrhotic livers of bile duct-ligated rats
Wei, C., Khoo, H., Lee, K.-H., & Hon, W. (2002) · Nitric Oxide · doi:10.1016/s1089-8603(02)00103-9 · Cited by 46
Experimental acute alcohol pancreatitis‐related liver damage and endotoxemia: synbiotics but not metronidazole have a protective effect
Marotta, F., BARRETO, R., WU, C., NAITO, Y., Gelosa, F., Lorenzetti, A., YOSHIOKA, M., & Fesce, E. (2005) · Chinese Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2005.00230.x · Cited by 46
MAFLD: an optimal framework for understanding liver cancer phenotypes
Crane, H., Gofton, C., Sharma, A., & George, J. (2023) · Journal of Gastroenterology · doi:10.1007/s00535-023-02021-7 · Cited by 46
Hydrogen sulphide and the hyperdynamic circulation in cirrhosis: a hypothesis
Ebrahimkhani, M. R., Mani, A. R., & Moore, K. P. (2005) · Gut · doi:10.1136/gut.2004.056556 · Cited by 45
Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection
Meiler, C. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i38.6031 · Cited by 45
Increased survival of cirrhotic patients with septic shock
Sauneuf, B., Champigneulle, B., Soummer, A., Mongardon, N., Charpentier, J., Cariou, A., Chiche, J., Mallet, V. O., Mira, J. P., & Pène, F. (2013) · Critical Care · doi:10.1186/cc12687 · Cited by 44
Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients
Kaji, K., Saikawa, S., Takaya, H., Fujinaga, Y., Furukawa, M., Kitagawa, K., Ozutsumi, T., Kaya, D., Tsuji, Y., Sawada, Y., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9040145 · Cited by 44
Tissue Coexpression of LBP and CD14 mRNA in a Mouse Model of Sepsis
Wang, S. C., Klein, R. D., Wahl, W. L., Alarcon, W. H., Garg, R. J., Remick, D. G., & Su, G. L. (1998) · Journal of Surgical Research · doi:10.1006/jsre.1998.5290 · Cited by 44
Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota
Jung, J. H., Kim, S. E., Suk, K. T., & Kim, D. J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.913842 · Cited by 42
Studies on endotoxin removal mechanism of adsorbents with amino acid ligands
Wei, Z., Huang, W., Li, J., Hou, G., Fang, J., & Yuan, Z. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2007.01.038 · Cited by 40
Lipopolysaccharides induce Smad2 phosphorylation through PI3K/Akt and MAPK cascades in HSC-T6 hepatic stellate cells
Kao, Y.-H., Chen, P., Wu, T.-Y., Lin, Y., Tsai, M., Lee, P., Tai, T.-S., Chang, H., & Sun, C. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.07.004 · Cited by 39
Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers
Madsen, B. S., Havelund, T., & Krag, A. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0044-1 · Cited by 38
Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease
Kaufmann, B. K., Seyfried, N., Hartmann, D., & Hartmann, P. (2023) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00017.2023 · Cited by 40
Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity
Márquez-Coello, M. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i4.1433 · Cited by 40
Gut–Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology
Maroni, L., Ninfole, E., Pinto, C., Benedetti, A., & Marzioni, M. (2020) · Cells · doi:10.3390/cells9030736 · Cited by 37
Uncoupling of sympathetic nervous system and hypothalamic‐pituitary‐adrenal axis in cirrhosis
Wiest, R., Moleda, L., Zietz, B., Hellerbrand, C., Schölmerich, J., & Straub, R. H. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05456.x · Cited by 37
TNF- α and Growth Hormone Resistance in Patients with Chronic Liver Disease
Picardi, A., Gentilucci, U. V., Zardi, E. M., Caccavo, D., Petitti, T., Manfrini, S., Pozzilli, P., & Afeltra, A. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/107999003321829944 · Cited by 37
A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis
Austin, A. S., Mahida, Y. R., Clarke, D., Ryder, S. D., & Freeman, J. G. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01809.x · Cited by 37
Characterisation of temporal microglia and astrocyte immune responses in bile duct‐ligated rat models of cirrhosis
Wright, G. A. K., Sharifi, Y., Newman, T. A., Davies, N. A., Vairappan, B., Perry, V. H., & Jalan, R. (2014) · Liver International · doi:10.1111/liv.12481 · Cited by 36
Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide‐induced fulminant hepatic failure
Chu, C. ‐., Wang, S., Lee, F., Chang, F. ‐., Lin, H., Hou, M., Chan, C. ‐., Wu, S.-L., Chen, C. ‐., Huang, H., et al. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00775.x · Cited by 35
Self-citation
Alcoholic hepatitis and HCV interactions in the modulation of liver disease
Punzalan, C., Bukong, T. N., & Szabó, G. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12399 · Cited by 34
Gut Microbiota and Liver Fibrosis: One Potential Biomarker for Predicting Liver Fibrosis
Li, Z., Ni, M., Yu, H., Wang, L., Zhou, X., Chen, T., Liu, G., & Gao, Y. (2020) · BioMed Research International · doi:10.1155/2020/3905130 · Cited by 35
Contribution of gut microbiota to drug-induced liver injury
Chu, H., Ai, Y., Cheng, Z., Yang, L., & Hou, X. (2023) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2023.06.008 · Cited by 35
Helicobacter pylori infection in hepatic encephalopathy: Relationship to plasma endotoxins and blood ammonia
Abdel‐Hady, H., Zaki, A., Badra, G., Lotfy, M., Selmi, C. F., Giorgini, A., El‐Sayed, M., & Badr, R. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00146.x · Cited by 34
The efficacy and the immunomodulatory effect of rifaximin in prophylaxis of spontaneous bacterial peritonitis in cirrhotic Egyptian patients
Mostafa, T. M., Badra, G., & Abdallah, M. (2015) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2015.7782 · Cited by 34
Implication of the intestinal microbiome in complications of cirrhosis
Bhat, M., Arendt, B. M., Bhat, V., Renner, E. L., Humar, A., & Allard, J. P. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i27.1128 · Cited by 36
Role of Intestinal Microbes in Chronic Liver Diseases
Xu, M., Luo, K., Li, J., Li, Y., Zhang, Y., Yuan, Z., Xu, Q., & Wu, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012661 · Cited by 34
Sequential changes in plasma cytokine and endotoxin levels in cirrhotic patients with bacterial infection
Wang, S.-S., Lee, F., Chan, C., Lu, R., Chao, Y., Lin, H., Wu, S.-L., Tsai, Y., & Lee, S. (2000) · Clinical Science · doi:10.1042/cs0980419 · Cited by 32
Self-citation
The Gut Microbiota-Derived Immune Response in Chronic Liver Disease
Won, S., Park, E., Jeong, J., Ganesan, R., Gupta, H., Gebru, Y. A., Sharma, S., Kim, D. J., & Suk, K. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158309 · Cited by 31
Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment
Xiong, Y., & Huang, J. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00489-0 · Cited by 30
The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial
Kimer, N., Meldgaard, M., Hamberg, O., Kronborg, T. M., Lund, A. M., Møller, H. J., Bendtsen, F., & Ytting, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264278 · Cited by 34
Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting
Kaser, A., Ludwiczek, O., Waldenberger, P., Jaschke, W. R., Vogel, W., & Tilg, H. (2002) · Liver International · doi:10.1034/j.1600-0676.2002.01666.x · Cited by 30
Downregulation effects of beta-elemene on the levels of plasma endotoxin, serum TNF-alpha, and hepatic CD14 expression in rats with liver fibrosis
Liu, J., Zhang, Z., Gao, J., Xie, J., Yang, L., & Hu, S. (2011) · Frontiers of Medicine · doi:10.1007/s11684-011-0111-4 · Cited by 30
Nitric oxide and the hyperdynamic circulation in cirrhosis: is there a role for selective intestinal decontamination?
Rasaratnam, B., Connelly, N. J., & Chin-Dusting, J. P. F. (2004) · Clinical Science · doi:10.1042/cs20040157 · Cited by 30
Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients
Dagher, Patch, Marley, Moore, & Burroughs (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00740.x · Cited by 30
The Role of the Microbiome in Liver Cancer
Moreno‐Gonzalez, M., & Beraza, N. (2021) · Cancers · doi:10.3390/cancers13102330 · Cited by 29
The Endocannabinoid System and Liver Diseases
Caraceni, P., Domenicali, M., & Bernardi, M. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01679.x · Cited by 29
Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions
Li, Y., Yu, Z., Li, A., & Ren, Z. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i28.3555 · Cited by 28
Sophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats
Qian, H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1822 · Cited by 27
Systemic Hemodynamic Changes in Mansonic Schistosomiasis With Portal Hypertension Treated by Azygoportal Disconnection and Splenectomy
de Cleva, R., Pugliese, V., Zilberstein, B., Saad, W. A., PINOTTI, H. W., & Laudanna, A. A. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00142-2 · Cited by 27
LRH1-driven transcription factor circuitry for hepatocyte identity: Super-enhancer cistromic analysis
Joo, M. S., Koo, J. H., Kim, T. H., Kim, Y. S., & Kim, S. G. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.056 · Cited by 28
Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma
Yu, Q., Wu, L., Ji, J., Feng, J., Dai, W., Li, J., Wu, J., & Guo, C. (2020) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s277870 · Cited by 27
Using machine learning methods to predict 28-day mortality in patients with hepatic encephalopathy
Zhang, Z., Wang, J., Han, W., & Li, Z. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02753-z · Cited by 26
Tumor necrosis factor alpha increases intestinal permeability in mice with fulminant hepatic failure
Li, G.-Z. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i36.5042 · Cited by 26
The bradykinin B2 receptor antagonist Icatibant (HOE 140) corrects avid Na+ retention in rats with CCl4-induced liver cirrhosis: possible role of enhanced microvascular leakage
WIRTH, K. J., Bickel, M., Hropot, M., Günzler, V., Heitsch, H., Ruppert, D., & Schölkens, B. A. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01281-8 · Cited by 26
Induction of a 72‐kDa heat shock protein and protection against lipopolysaccharide‐induced liver injury in cirrhotic rats
Mikami, K., Otaka, M., Goto, T., Miura, K., Ohshima, S., Yoneyama, K., Lin, J.-G., Watanabe, D., Segawa, D., Kataoka, E., et al. (2004) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2004.03401.x · Cited by 26
Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review
Gu, X., Lu, Q., Zhang, C., Tang, Z., & Chu, L. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1732319 · Cited by 26
Systemic inflammation as a risk factor for portal vein thrombosis in cirrhosis: a prospective longitudinal study
Nery, F., Carneiro, P., Correia, S., Macedo, C. S., Gandara, J., Lopes, V., Valadares, D., Ferreira, S., de Oliveira, J. P. F., Gomes, M. T., et al. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001982 · Cited by 25
The Superantigen Toxic Shock Syndrome Toxin 1 Alters Human Aortic Endothelial Cell Function
Kulhánková, K., Kinney, K. J., Stach, J. M., Gourronc, F. A., Grumbach, I. M., Klingelhutz, A. J., & Salgado‐Pabón, W. (2017) · Infection and Immunity · doi:10.1128/iai.00848-17 · Cited by 23
The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).
Benten, D., Wiesch, J. S. Z., Sydow, K., Koops, A., Buggisch, P., Böger, R. H., Gaydos, C. A., Won, H., Franco, V., Lohse, A. W., et al. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-107 · Cited by 24
The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure
Kim, S. E., Park, J. W., Kim, H. S., Jang, M. K., Suk, K. T., & Kim, D. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111680 · Cited by 24

Authors: Lin, R.-S., Lee, F.-Y., Lee, S.-D., Tsai, Y.-T., Lin, H. C., Rei-Hwa, L., Wan-Ching, H., Cheng-Chun, H., Sun-Sang, W., & Kwang-Juei, L.
Affiliations: Taipei Veterans General Hospital (TW)
National Yang Ming University (TW)
Corresponding author: Lee, Fa-Yauh
ORCID: Lee, Fa-Yauh
Lee, Shou-Dong
Lin, Han Chieh
Venue: Journal of Hepatology
Publisher: Elsevier BV
Published: 1995-02
Volume: 22
Issue: 2
Pages: 165-172
ISSN: 0168-8278 (ISSN-L)
DOI: 10.1016/0168-8278(95)80424-2
OpenAlex: W2155112010
Cited by: 355
References: 40
Citations by year: 2026: 4 · 2025: 10 · 2024: 8 · 2023: 19 · 2022: 15 · 2021: 16 · 2020: 23 · 2019: 16 · 2018: 11 · 2017: 14 · 2016: 16 · 2015: 31 · 2014: 13 · 2013: 14 · 2012: 27
FWCI: 4.26
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Hepatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Keywords: endotoxemia, plasma endotoxin, chronic liver disease, liver cirrhosis, chronic hepatitis, esophageal varices, hyperdynamic circulation, portal hypertension, acute exacerbation, liver dysfunction severity, collateral circulation
MeSH terms: Blood Circulation, Chronic Disease, Endotoxins, Esophageal and Gastric Varices, Female, Hepatitis, Humans, Liver Cirrhosis, Liver Diseases, Male, Middle Aged

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophaegeal varices, and hyperdynamic circulation.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks